Cas no 193068-56-3 (4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone)
4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone Chemical and Physical Properties
Names and Identifiers
-
- 4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone
- [6-(trifluoromethyl)pyrimidin-4-yl]hydrazine
- AKOS037653209
- 4-hydrazinyl-6-(trifluoromethyl)pyrimidine
- CLJMJFUFISWIII-UHFFFAOYSA-N
- Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)-
- SCHEMBL21767967
- 193068-56-3
- GS-1953
- DTXSID10777771
- AKOS030241170
-
- MDL: MFCD29042707
- Inchi: 1S/C5H5F3N4/c6-5(7,8)3-1-4(12-9)11-2-10-3/h1-2H,9H2,(H,10,11,12)
- InChI Key: CLJMJFUFISWIII-UHFFFAOYSA-N
- SMILES: FC(C1C=C(N=CN=1)NN)(F)F
Computed Properties
- Exact Mass: 178.04675
- Monoisotopic Mass: 178.04663066g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 148
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.1
- Topological Polar Surface Area: 63.8?2
Experimental Properties
- PSA: 62.77
4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| eNovation Chemicals LLC | D634631-5g |
Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)- |
193068-56-3 | 95% | 5g |
$985 | 2024-08-03 | |
| eNovation Chemicals LLC | D634631-10g |
Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)- |
193068-56-3 | 95% | 10g |
$1290 | 2024-08-03 | |
| eNovation Chemicals LLC | D634631-5g |
Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)- |
193068-56-3 | 95% | 5g |
$985 | 2025-02-27 | |
| eNovation Chemicals LLC | D634631-10g |
Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)- |
193068-56-3 | 95% | 10g |
$1290 | 2025-02-27 | |
| eNovation Chemicals LLC | D634631-5g |
Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)- |
193068-56-3 | 95% | 5g |
$985 | 2025-02-28 | |
| eNovation Chemicals LLC | D634631-10g |
Pyrimidine, 4-hydrazinyl-6-(trifluoromethyl)- |
193068-56-3 | 95% | 10g |
$1290 | 2025-02-28 |
4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone Related Literature
-
Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
-
Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
-
Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
Additional information on 4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone
In-Depth Analysis of 4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone (CAS No. 193068-56-3)
4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone (CAS No. 193068-56-3) is a specialized heterocyclic compound that has garnered significant attention in pharmaceutical and agrochemical research. This compound belongs to the pyrimidinone family, characterized by its unique trifluoromethyl substitution and hydrazone functional group. Its molecular structure makes it a valuable intermediate in the synthesis of bioactive molecules, particularly in drug discovery and crop protection applications.
The growing interest in 6-(trifluoromethyl)pyrimidinone hydrazone derivatives stems from their potential as enzyme inhibitors and antimicrobial agents. Researchers are actively exploring its role in targeting diseases such as cancer and bacterial infections, aligning with the global focus on novel therapeutic solutions. The trifluoromethyl group enhances the compound's metabolic stability and lipophilicity, key factors in improving drug bioavailability—a hot topic in modern medicinal chemistry.
From a synthetic chemistry perspective, CAS 193068-56-3 demonstrates remarkable versatility. Its hydrazone moiety allows for diverse chemical modifications, enabling the creation of libraries of derivatives for high-throughput screening. This aligns perfectly with current trends in combinatorial chemistry and fragment-based drug design, addressing the pharmaceutical industry's need for efficient lead compound optimization.
In agrochemical applications, the 4(1H)-pyrimidinone scaffold has shown promise in developing new-generation pesticides with improved environmental profiles. The 6-trifluoromethyl substitution particularly enhances pesticidal activity while maintaining selectivity—a crucial consideration in sustainable agriculture. This connects with the increasing consumer demand for eco-friendly crop protection solutions and reduced chemical residues in food production.
The physicochemical properties of 4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone contribute to its research utility. With moderate solubility in organic solvents and specific hydrogen bonding capabilities, it serves as an excellent building block in molecular design. These characteristics are frequently searched by chemists looking for heterocyclic building blocks with balanced polarity for drug formulation.
Recent patent analyses reveal growing intellectual property activity surrounding pyrimidinone hydrazone derivatives, particularly in antiviral applications. This reflects the compound's relevance in addressing emerging viral threats—a major concern in post-pandemic research priorities. The 193068-56-3 scaffold appears in several patent families claiming broad-spectrum antiviral activity, making it a compound of significant commercial interest.
Quality control of CAS 193068-56-3 presents specific analytical challenges that resonate with current analytical chemistry discussions. The compound's stability under various storage conditions and its purity assessment methods are frequent topics in pharmaceutical forums. Advanced techniques like HPLC-MS and NMR spectroscopy are typically employed to characterize this material, addressing researchers' needs for reliable characterization protocols.
From a market perspective, the demand for 6-(trifluoromethyl)pyrimidinone derivatives shows steady growth, driven by both pharmaceutical and agricultural sectors. Suppliers are increasingly offering custom synthesis services for this compound, responding to the research community's need for tailored molecular building blocks. This trend aligns with the broader shift toward specialized chemical solutions in life sciences research.
The environmental fate of 4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone has become a subject of regulatory interest, particularly regarding its biodegradation pathways. This connects with the chemical industry's focus on green chemistry principles and sustainable molecular design—a key consideration for researchers selecting compounds for development programs.
In conclusion, 4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone (CAS No. 193068-56-3) represents a versatile and valuable chemical entity with broad applications across multiple scientific disciplines. Its unique structural features continue to inspire innovative research in medicinal chemistry and crop science, while its commercial availability supports widespread investigation. As research into fluorinated heterocycles advances, this compound is poised to remain an important tool in the development of next-generation bioactive molecules.
193068-56-3 (4(1H)-Pyrimidinone, 6-(trifluoromethyl)-, hydrazone) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)